MGMT and cancer: The physiological conditions associated with aberrant MLH1 and MGMT promoter methylation in colorectal mucosa from healthy individuals undergoing screening colonoscopy were previously analyzed by Menigatti et al..14 The authors concluded that the epigenetic signatures of cancers may have early-stage, normal-tissue counterparts that reflect potentially important aspects of the initial carcinogenic process.